SWM
AZN icon

SHP Wealth Management’s AstraZeneca AZN Stock Holding History

SHP Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$81.2K Sell
412
-129
-24% -$24.9K 0.01% 420
2025
Q4 		$99.5K Buy
+541
New +$94.9K 0.01% 353

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

SHP Wealth Management's AZN Position: Q1 2026 in Review

SHP Wealth Management reduced its AstraZeneca (AZN) stake by 24% in Q1 2026, selling an estimated $24.9K and leaving 412 shares worth $81.2K. The position accounts for 0.01% of the portfolio, ranked #420.

SHP Wealth Management first reported a position in AZN in Q4 2025 and has held it in 2 quarters since. The position peaked at $99.5K in Q4 2025. 1,382 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • SHP Wealth Management held 412 shares of AstraZeneca worth $81.2K as of Q1 2026.
  • SHP Wealth Management sold 129 AstraZeneca shares in Q1 2026, an estimated $24.9K.
  • AstraZeneca made up 0.01% of SHP Wealth Management's portfolio in Q1 2026, its #420 holding.
  • SHP Wealth Management first reported a position in AstraZeneca in Q4 2025 and has held it in 2 quarters since.
  • SHP Wealth Management's AstraZeneca position peaked at $99.5K in Q4 2025.
  • 1,382 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on SHP Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.